NIH Partners with 10 Pharma Companies to Tackle Major Disease Targets
The National Institutes of Health and 10 pharmaceutical companies have launched a partnership to transform the current model for identifying and validating promising biological targets for Type 2 diabetes, Alzheimer’s disease, lupus and rheumatoid arthritis. Read the full story